Recent Updates
Recently added Catalysts
REGN

Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases Regeneron Retains U.S. Commercialization Rights, Receives

Key Takeaway: Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases Regeneron Retains U.S. Commercialization Rights, Receives

Full Press Release Details

Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases Regeneron Retains U.S. Commercialization Rights, Receives.
Last updated: Oct 18, 2006